Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters








Language
Year range
1.
Article | IMSEAR | ID: sea-194828

ABSTRACT

Adolescence is the rapid growing period when mainly the physical changes are important. 95% girls attain menarche at the age group of 10 to 16 yrs, the peak being 13yrs. Among them, not less than 50% of female are said to experience some discomfort or pain in relation to menstruation. Kashtartava is a symptom mentioned in various Yoni vyapads, Vata being the main causative factor for this condition, which is commonly compared with dysmenorrhoea by cotemporary science. Conventional treatment of primary dysmenorrhoea consists of non-steroidal and anti-inflammatory drugs, hormonal therapy which causes unwanted side effects. Hence Rutukari Vati which is mentioned in Bheshaja Samhita for Kashtartava having the properties like, Vedanashamaka, Arthavajanana have been selected for the planned study. Design of Study: A Single blind comparative clinical study of two groups, trial and control, consisting of 15 subjects in each with pre-test and post-test design. Group A was given Rutukarivati and Group B was given Kumaryasava 25ml twice daily after food. Result: Rutukarivati contains most of the drugs with Tiktha and Katu rasa, Usnaveerya property and Vatakaphahara property; it is effective in controlling pain and regularizing the cycle. On comparison of overall effect of both groups has more significant result but percentage wise group A is more effective than group B. Mild increase in amount of bleeding was noted in patients in group A. It may be because of most of the ingredients in Rutukarivati are Artavajanana and Apanavatashaman.

2.
Chinese Traditional and Herbal Drugs ; (24): 2624-2628, 2018.
Article in Chinese | WPRIM | ID: wpr-851940

ABSTRACT

Objective To assess the efficacy of Tiaojing Huoxue CapsuleS for the primary dysmenorrhoea (PD). Methods A total of 300 women with PD were enrolled and randomly divided into the control and treatment group, which were administrated with placebo and Tiaojing Huoxue Capsules for three menstrual cycles, respectively. The efficacy of Tiaojing Huoxue Capsule was evaluated by visual analogue scale (VAS) and traditional Chinese medicine (TCM) syndrome scores. Results The effective rate of VAS was 62.43% in the experiment group with statistical significance when compared with the control group (P < 0.01). Similarly, the total effective rate in the treatment group was 76.30% while that in the control group was 36.67% after treatment of three menstrual cycles. Conclusion Tiaojing Huoxue Capsules can relieve the alleviating pain for women with PD.

SELECTION OF CITATIONS
SEARCH DETAIL